Clinical Trial Update: Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3) [NA]

View source ↗

Summary

This clinical trial update outlines Aim 3 of a study evaluating a behavioral intervention to reduce anxiety by modifying threat interpretation bias in Huntingto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease
• Parkinson Disease

Snippet

Sponsor: University of Virginia | Conditions: Huntington Disease, Parkinson Disease | NA | Status: RECRUITING